No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1037 |
4. Check minimum number of eventsNone |
1037 |
5. Include endpointsNone |
1037 |
6. Filter based on genotype QC (FinnGen only) |
1008 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D31
Name in latin
Neoplasma benignum conjunctivae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Conjunctiva
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Conjunctiva
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 9125 | 4799 | 4289 |
| Only index persons | 8425 | 4519 | 3906 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.14 | 0.12 |
| Only index persons | 0.16 | 0.17 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 46.75 | 47.84 | 45.62 |
| Only index persons | 46.86 | 48.15 | 45.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1008 | 598 | 410 |
| Unadjusted period prevalence (%) | 0.22 | 0.23 | 0.21 |
| Median age at first event (years) | 53.03 | 50.55 | 56.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_CONJUNCTIVA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.859 [0.75, 0.98] | 0.028 |
| Birth year | 0.999 [0.99, 1.01] | 0.882 |
During the follow-up period (1.1.1998 — 31.12.2019), 382 out of 3763 females with CD2_BENIGN_CONJUNCTIVA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_CONJUNCTIVA | 0.942 [0.82, 1.08] | 0.393 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 471 out of 3295 males with CD2_BENIGN_CONJUNCTIVA died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_CONJUNCTIVA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | 0.141% |
| 5 | 0.466% | 1.121% |
| 10 | 1.353% | 2.747% |
| 15 | 2.688% | 5.275% |
| 20 | 5.024% | 8.955% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONJUNCTIVA – Benign neoplasm: Conjunctiva
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data